UPDATE: Stifel Upgrades Blueprint Medicines (BPMC) to Buy
Tweet Send to a Friend
(Updated - January 25, 2022 5:28 AM EST)
Stifel analyst Bradley Canino upgraded Blueprint Medicines (NASDAQ: BPMC) from Hold ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stifel analyst Bradley Canino upgraded Blueprint Medicines (NASDAQ: BPMC) from Hold ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
